American Conference Institute’s Hatch-Waxman Series Advisory board was created as a part of ACI’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of all-in-house advisers, including Chief IP and very senior IP/Patent counsel from the leading brand name and generic pharmaceutical companies in the country and in some cases the world. This ‘inner circle’ counsels ACI on the impact of litigation trends and emerging topics.

Advisory Board

Ryan M. Daniel

AGC, Corporate and Business Transactions Fresenius Kabi

Stephanie Donahue

Head of Global Patent Litigation
Global Intellectual Property Department
Legal, Ethics & Business Integrity

Serena Farquharson Torres

Executive Director, Assistant General Counsel Bristol Myers Squibb

Linda Friedlieb

Division Counsel AbbVie

Colin Heitzmann

Vice President, IP and Business Development Daiichi Sankyo, Inc.

Jenny Johnson

Vice President, IP Endo Pharmaceuticals

Staci Julie

SVP and Chief IP Counsel Teva Pharmaceuticals

Neema Kumar

Vice President, IP, North America Sandoz

Mary Morry

Counsel, IP Litigation Merck & Company

Jeffrey N. Myers, Ph.D.

Vice President & Assistant General Counsel Pfizer Inc

Aaron Pereira

Senior Director of Patents Ferring Pharmaceuticals

Pearl T. L. Siew

Senior Vice President and Head of IP Design Therapeutics

Lars P. Taavola

VP, Chief IP Counsel & General Counsel, Specialty Generics Mallinckrodt Pharmaceuticals

Andrea Tiglio

Executive Director
Assistant General Counsel, IP
Jazz Pharmaceuticals

Maryll W. Toufanian

Senior Vice President, Regulatory Strategy and Government Affairs Amneal Pharmaceuticals

Kevin Zive

Vice President, Global General Counsel,
Head of IP
Apotex Inc.

Emeritus Members

Stephen R. Auten

Partner, Chair of Pharmaceutical & Life Sciences Litigation Taft Stettinius & Hollister LLP
(Former Vice President, IP, Sandoz, Inc.)

Guy Donatiello

Former SVP of IP Endo Pharmaceuticals

George W. Johnston

Counsel Gibbons P.C.
(Former Vice President & Chief Patent Counsel, Hoffmann-La Roche)

Honorable Kathleen M. O’Malley (Ret.)

Of Counsel Sullivan & Cromwell LLP

Honorable Teresa Rea

Consultant Rea Consulting LLC Former Acting Director of the USPTO

Shashank Upadhye

Partner Upadhye Tang LLP
(Former Vice President – Global Intellectual Property, Apotex, Inc.)

Peter Waibel

Former Head, US Patent Litigation Novartis Pharmaceuticals Corporation